Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: A combined in vivo electrochemical and electrophysiological study

Neuroscience

Volumn 85, Issue 4, 1998, Pages 1173-1182

  Sotty, F ^a   Souliere F ^a   Brun, P ^a   Chouvet, G ^a   Steinberg, R ^b   Soubrie P ^b   Renaud, B ^a   Suaud Chagny, M F ^a  

^a UNIVERSITÉ LYON 1   (France)

^b SANOFI   (France)

Author keywords

Caudal nucleus accumbens; Electrochemistry; Electrophysiology; Rostral nucleus accumbens; Ventral tegmental area

Indexed keywords

CALCIUM CHLORIDE; DOPAMINE; NEUROTENSIN; PARGYLINE; URETHAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DOPAMINE RELEASE; MALE; NERVE CELL EXCITABILITY; NONHUMAN; NUCLEUS ACCUMBENS; POTENTIOMETRY; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANIMALS; DOPAMINE; ELECTROCHEMISTRY; ELECTROPHYSIOLOGY; EVOKED POTENTIALS; MALE; NEURONS; NEUROTENSIN; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VENTRAL TEGMENTAL AREA;

EID: 0032144799     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00691-X     Document Type: Article

References (29)

1. 1. Akaoka H., Saunier C. F., Chergui K., Charléty P., Buda M. and Chouvet G. (1992) Combining in vivo volume-controlled pressure microejection with extracellular unit recording. J. Neurosci. Meth. 42, 119-128.
2. 2. Bunney B. S. and Grace A. A. (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci. 23, 1715-1728.
3. 3. Cador M., Rivet J. M., Kelley A. E., Le Moal M. and Stinus L. (1989) Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res. 486, 357-363.
4. 4. Cervo L., Rossi C., Tatarczynska E. and Samanin R. (1992) Antidepressant-like effect of neurotensin administered in the ventral tegmental area in the forced swimming test. Psychopharmacology 109, 369-372.
5. 5. Charléty P. J., Grenhoff J., Chergui K., De La Chapelle B., Buda M., Svensson T. H. and Chouvet G. (1991) Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate. Acta physiol. scand. 142, 105-112.
6. 6. Christie M. J., James L. B. and Beart P. M. (1985) An excitant amino acid projection from the medial prefrontal cortex to the anterior part of nucleus accumbens in the rat. J. Neurochem. 45, 477-482.
7. 7. Elliott P. J. and Nemeroff C. B. (1986) Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity. Neurosci. Lett. 68, 239-244.
8. 8. Fuxe K., Agnati L. F., Andersson K., Eneroth P., Härfstrand A., Goldstein M. and Zoli M. (1984) Studies on neurotensin-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Neurochem. Int. 6, 737-750.
9. 9. Gonon F., Buda M. and Pujol J. F. (1984) Treated carbon fiber electrodes for measuring catechols and ascorbic acid. In Measurement of Neurotransmitter Release in vivo (ed. Marsden C. A.), pp. 153-171. John Wiley, Chichester, U.K.
10. 10. Gonon F. (1986) Control of dopamine release by dopamine receptors and by impulse flow as studied by in vivo voltammetry. In Neurochemical Analysis of the Conscious Brain: Voltammetry and Push-Pull Perfusion (eds Myers M. D. and Knott P. H.), Ann. N. Y. Acad. Sci. 473, 160-169.
11. 11. Gonon F. G. (1988) Non linear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24, 19-28.
12. 12. Grace A. A. and Bunney B. S. (1983) Intracellular and extracellular electrophysiology of nigral dopaminergic neurons - 1. Identification and characterization. Neuroscience 10, 301-315.
13. 13. Grace A. A. and Bunney B. S. (1986) Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J. Pharmac. exp. Ther. 238, 1092-1100.
14. 14. Gully D., Labeeuw B., Boigegrain R., Oury-Donat F., Bachy A., Poncelet M., Steinberg R., Suaud-Chagny M. F., Santucci V., Vita N., Pecceu F., Labbé-Jullié C., Kitabgi P., Soubrié P., Le Fur G. and Maffrand J. P. (1997) Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J. Pharmac. exp. Ther. 280, 802-812.
15. 15. Kalivas P. W., Burgess S. K., Nemeroff C. B. and Prange A. J. (1983) Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 8, 495-505.
16. 16. Kalivas P. W. and Duffy P. (1990) Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J. Neurosci. 10, 2940-2949.
17. 17. Kalivas P. W. (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18, 75-113.
18. 18. Laitinen K., Crawley J. N., Mefford I. N. and De Witte Ph. (1990) Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens. Brain Res. 523, 342-346.
19. 19. Le F., Cusack B. and Richelson E. (1996) The neurotensin receptor: is there more than one subtype? Trends pharmac. Sci. 17, 1-3.
20. 20. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, Sydney, Australia.
21. 21. Phillipson O. T. and Griffiths A. C. (1985) The topographic order of inputs to nucleus accumbens in the rat. Neuroscience 16, 275-296.
22. 22. Pozza M. F., Küng E., Bischoff S. and Olpe H. R. (1988) The neurotensin analog xenopsin excites nigral dopamine neurons. Eur. J. Pharmac. 145, 341-343.
23. 23. Rivest R., Jolicoeur F. B. and Marsden C. A. (1991) Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo. Neuropharmacology 30, 25-33.
24. 24. Seutin V., Massotte L. and Dresse A. (1989) Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro. Neuropharmacology 28, 949-954.
25. 25. Shi W. X. and Bunney B. S. (1991) Effects of neurotensin on midbrain dopamine neurons: are they mediated by formation of a neurotensin-dopamine complex? Synapse 9, 157-164.
26. 26. Shi W. X. and Bunney B. S. (1991) Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity. Brain Res. 543, 315-321.
27. 27. Steinberg R., Brun P., Fournier M., Souilhac J., Rodier D., Mons G., Terranova J. P., Le Fur G. and Soubrié P. (1994) SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission. Neuroscience 59, 921-929.
28. 11] neurotensin on mesolimbic dopaminergic function. Neuropeptides 28, 43-50.
29. 29. Suaud-Chagny M. F., Chergui K., Chouvet G. and Gonon F. (1992) Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience 49, 63-72.